Aspirin as good as screening for bowel cancer

Regular low-dose aspirin is just as effective in reducing colorectal cancer incidence and mortality as FOBT or sigmoidoscopy screening, according to a systematic review.

The authors say the finding from 15 randomised trials with over 200,000 people has “potentially large implications for policy making in cancer prevention”.

They found that aspirin reduced colorectal cancer incidence by 14% compared with placebo, which was around the same